<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>HIV/AIDS News &#38; Information &#187; Health</title>
	<atom:link href="http://www.hiv-infected.com/category/health/feed" rel="self" type="application/rss+xml" />
	<link>http://www.hiv-infected.com</link>
	<description></description>
	<lastBuildDate>Fri, 27 Jan 2012 04:24:36 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Test and treat strategies for Helicobacter: RESULTS part 2</title>
		<link>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-results-part-2.html</link>
		<comments>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-results-part-2.html#comments</comments>
		<pubDate>Mon, 23 Jan 2012 03:59:30 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cost analysis]]></category>
		<category><![CDATA[Cost effectiveness]]></category>
		<category><![CDATA[Decision analysis]]></category>
		<category><![CDATA[Dyspepsia]]></category>
		<category><![CDATA[Helicobacter pylori]]></category>
		<category><![CDATA[Serology]]></category>
		<category><![CDATA[Urea breath test]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2659</guid>
		<description><![CDATA[The ICER of C-UBT versus serology ranged from $57/cure to over $32270/cure in sensitivity analysis and ex­ceeded $2000/cure only with variation in C-UBT cost and serology specificity (Table 5). In no case did C-UBT domi­nate serology. However, serology became dominant over 13C-UBT when the specificity of 13C-UBT fell below 81%. Two-way sensitivity analysis: Because the [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-results-part-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Test and treat strategies for Helicobacter: RESULTS</title>
		<link>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-results.html</link>
		<comments>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-results.html#comments</comments>
		<pubDate>Sun, 22 Jan 2012 04:03:26 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cost analysis]]></category>
		<category><![CDATA[Cost effectiveness]]></category>
		<category><![CDATA[Decision analysis]]></category>
		<category><![CDATA[Dyspepsia]]></category>
		<category><![CDATA[Helicobacter pylori]]></category>
		<category><![CDATA[Serology]]></category>
		<category><![CDATA[Urea breath test]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2657</guid>
		<description><![CDATA[RESULTS Base case scenario: The number of endoscopies per 1000 pa­tients was lowest with the C-UBT strategy, higher with serology and highest with empirical ranitidine therapy (Table 3). The number of H pylori eradica­tion regimens prescribed per 1000 patients was lowest with empirical ranitidine (200.1), highest with serology and intermediate with the 13C-UBT. In the [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-results.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Test and treat strategies for Helicobacter: Cost inputs</title>
		<link>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-cost-inputs.html</link>
		<comments>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-cost-inputs.html#comments</comments>
		<pubDate>Sat, 21 Jan 2012 03:57:26 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cost analysis]]></category>
		<category><![CDATA[Cost effectiveness]]></category>
		<category><![CDATA[Decision analysis]]></category>
		<category><![CDATA[Dyspepsia]]></category>
		<category><![CDATA[Helicobacter pylori]]></category>
		<category><![CDATA[Serology]]></category>
		<category><![CDATA[Urea breath test]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2654</guid>
		<description><![CDATA[Several sources were used to estimate locally relevant direct costs for the resources consumed in the model (Table 2). Wholesale drug costs were determined through a survey of local pharmacies including the Hamilton Health Sciences Corporation (McMaster Site) Outpatient Phar­macy, Hamilton, Ontario. A 10% pharmacy markup was added to the wholesale price, as well as [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-cost-inputs.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Test and treat strategies for Helicobacter: PATIENTS AND METHODS part 2</title>
		<link>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-patients-and-methods-part-2.html</link>
		<comments>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-patients-and-methods-part-2.html#comments</comments>
		<pubDate>Fri, 20 Jan 2012 03:57:29 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cost analysis]]></category>
		<category><![CDATA[Cost effectiveness]]></category>
		<category><![CDATA[Decision analysis]]></category>
		<category><![CDATA[Dyspepsia]]></category>
		<category><![CDATA[Helicobacter pylori]]></category>
		<category><![CDATA[Serology]]></category>
		<category><![CDATA[Urea breath test]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2651</guid>
		<description><![CDATA[In each arm, the first-line regimen for H pylori eradication was omeprazole 20 mg, clarithromycin 500 mg and metroni­dazole 500 mg bid for seven days (OCM). The second-line regimen, used for OCM failures, was omeprazole 20 mg bid, clarithromycin 500 mg bid and amoxicillin 1000 mg bid for seven days. When a third attempt at [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-patients-and-methods-part-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Test and treat strategies for Helicobacter: PATIENTS AND METHODS</title>
		<link>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-patients-and-methods.html</link>
		<comments>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-patients-and-methods.html#comments</comments>
		<pubDate>Thu, 19 Jan 2012 03:54:08 +0000</pubDate>
		<dc:creator>Steve</dc:creator>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cost analysis]]></category>
		<category><![CDATA[Cost effectiveness]]></category>
		<category><![CDATA[Decision analysis]]></category>
		<category><![CDATA[Dyspepsia]]></category>
		<category><![CDATA[Helicobacter pylori]]></category>
		<category><![CDATA[Serology]]></category>
		<category><![CDATA[Urea breath test]]></category>

		<guid isPermaLink="false">http://www.hiv-infected.com/?p=2648</guid>
		<description><![CDATA[Decision tree: The decision-analytic model was constructed using DATA software (TreeAge Software Inc, Williams- town, Massachusetts). A hypothetical cohort of 1000 pa­tients under the age of 50 years who had presented to their primary care practitioner with a new complaint of dyspepsia and did not use nonsteroidal anti-inflammatory drugs was used. Three initial management strategies [...]]]></description>
		<wfw:commentRss>http://www.hiv-infected.com/2012/01/test-and-treat-strategies-for-helicobacter-patients-and-methods.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

